The pharmaceutical lobbying group’s aura of invincibility has faded. The U.S. Senate recently passed a new bill, leaving the pharmaceutical sector licking its wounds and paving the way for a significant drug pricing overhaul. If the comprehensive climate and tax reform measure that the Senate passed over the weekend becomes law, the U.S. government will […]

The post Patient Groups Rejoice As Pharma Dismisses Drug Pricing Law first appeared on World Pharma Today.